Diabetes care

454 articles · Since 2004

Articles, page 2

Oral Wegovy sounds easy, but the reality is more complicated [PODCAST]

April 13, 2026Apr 13, 2026

Is the new oral Wegovy pill a breakthrough or a risk most patients never hear about? Shiv K. Goel, an internal medicine and functional medicine physician, joins the show to unpack his KevinMD article, "Oral Wegovy: the miracle and the…

Listen on Apple Podcasts · Spotify

Listen and followApple Podcasts Spotify YouTubeMore apps · Browse all episodes

The Podcast by KevinMD

Why weight regain is a predictable biological response after stopping GLP-1s [PODCAST]

The Podcast by KevinMD

April 6, 2026Apr 6, 2026

Obesity medicine physician Jessica Duncan discusses the article "GLP-1 weight regain: Why stopping medication leads to weight return." Jessica explains that expecting to maintain weight loss after abruptly stopping GLP-1 therapy is unrealistic because it ignores the physiological forces that…

Listen on Apple Podcasts · Spotify

Listen and followApple Podcasts Spotify YouTubeMore apps · Browse all episodes

Obesity medicine physician Jessica Duncan discusses the article “GLP-1 weight regain: Why stopping medication leads to weight return.” Jessica explains that expecting to maintain weight loss after abruptly stopping GLP-1 therapy is unrealistic because it ignores the physiological forces that defend a person’s prior weight. She critiques a marketplace that …

The Podcast by KevinMD

Insulin resistance is a survival mechanism, not a broken system [PODCAST]

The Podcast by KevinMD

March 23, 2026Mar 23, 2026

Metabolic health educator Kevin Whitt discusses his article "Insulin resistance is not a disease: a metabolic reframe." Kevin argues that the skyrocketing rates of Type 2 diabetes are not the result of defective biology, but rather a predictable response to…

Listen on Apple Podcasts · Spotify

Listen and followApple Podcasts Spotify YouTubeMore apps · Browse all episodes

Metabolic health educator Kevin Whitt discusses his article “Insulin resistance is not a disease: a metabolic reframe.” Kevin argues that the skyrocketing rates of Type 2 diabetes are not the result of defective biology, but rather a predictable response to chronically elevated blood sugar. The conversation challenges the traditional medical …

Real physician voices, twice a week

Free, and one click to unsubscribe.

Conditions and diseases

Diabetic foot complications prevention: Stopping amputation before it starts

Wendy Kang

March 16, 2026Mar 16, 2026

Since 2023, while volunteering at an amputee sports competition in Los Angeles, I encountered athletes whose amputations resulted from complications of diabetes. In many cases, limb loss did not begin with a catastrophic injury, but with gaps in preventive care…

Participants traveled long distances to attend the competition, seeking peer support and health information that was often unavailable in their home …

Drugs and prescribing

GLP-1 weight regain: Why stopping medication leads to weight return

Jessica Duncan, MD

March 4, 2026Mar 4, 2026

Stopping a GLP-1 abruptly and expecting maintenance of weight loss is not realistic. Even replacing it with a standard "eat less, move more" plan is not sufficient as it ignores what we know about hunger regulation and metabolic adaptation. A…

Stopping a GLP-1 abruptly and expecting maintenance of weight loss is not realistic. Even replacing it with a standard “eat less, move more” plan is not sufficient as it ignores what we know about hunger regulation and metabolic adaptation. A reduced-calorie diet and 30 minutes of daily walking, while helpful, are rarely sufficient to overcome the physiological forces defending prior weight.

Weight maintenance after significant loss requires managing cravings, psychological hunger …

Conditions and diseases

Insulin resistance is not a disease: a metabolic reframe

Kevin Whitt

February 25, 2026Feb 25, 2026

Type 2 diabetes and metabolic disease are now so common that they are treated as an expected part of modern life rather than as a systemic failure. Roughly 90 percent of American adults are now prediabetic or diabetic, and most are unaware of it. This progression quietly opens the door to heart disease, non-alcoholic fatty liver disease, cancer, neurodegeneration, and other chronic illnesses that are then managed downstream.

We are not …

Conditions and diseases

From glucose to vascular health: the future of diabetes care

Palma Shaw, MD

February 25, 2026Feb 25, 2026

Historically, diabetes management focused on blood glucose control and preventing severe complications such as neuropathy and amputation. Over the past two decades, this limited view has proven insufficient for long-term health. Many now emphasize risk factor management, lifestyle changes, and…

The vascular health risk of a diabetes surge

Diabetes is an epidemic: In the last decade alone, the number of adults living with the disease globally …

Drugs and prescribing

Beyond weight loss: the expanding benefits of GLP-1 receptor agonists

Zehra Haider, MD

February 9, 2026Feb 9, 2026

Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) were introduced to help manage type 2 diabetes. They improve glycemic control and promote weight loss, which we all know are essential for long-term outcomes. In practice, I’ve seen that their impact goes beyond these traditional targets. Patients often benefit from cardiovascular protection and kidney improvements, and emerging data show advantages in areas we did not initially anticipate, such as sleep apnea, joint health, …

Conditions and diseases

Geriatric diabetes management: Why strict A1c targets can harm seniors

George James

February 7, 2026Feb 7, 2026

According to the CDC, nearly 1 in 3 Americans over age 65 live with diabetes. However, our health care system treats diabetes as if all adults are metabolically and functionally the same. In their attempt to maximize glycemic control, it’s not uncommon for elderly patients to experience hypoglycemic episodes, resulting in falls and confusion among other issues, exacerbating other health conditions while taking a mental and emotional toll on …

Drugs and prescribing

Oral Wegovy: the miracle and the mess of the new GLP-1 pill

Shiv K. Goel, MD

February 2, 2026Feb 2, 2026

A patient stopped me in the hallway recently, not in an exam room, not seated, not "ready" for a clinical conversation. Just a human being catching me between visits and asking a question that felt heavier than any lab result:…

A patient stopped me in the hallway recently, not in an exam room, not seated, not “ready” for a clinical conversation. Just a human being catching me between visits and asking a question that felt heavier than any lab result:

“Doc, is this finally the thing that will work? Or is it just another trap?”

That question is the GLP-1 era in one sentence. And with the launch of oral Wegovy, it …

Conditions and diseases

Why fear-based approaches fail in chronic illness care

Bridgette Johnson, PhD, RN

January 9, 2026Jan 9, 2026

In caring for patients with chronic illness, we often assume that if people truly understood the consequences of poor disease management, they would change. We explain complications, cite lab values, outline risks, and sometimes lean into fear in hopes that it will motivate action. When patients do not follow recommendations, we label them as noncompliant or unmotivated. Yet chronic illness is not managed in exam rooms or hospital beds. It …

The Podcast by KevinMD

Catching type 1 diabetes before it becomes life-threatening [PODCAST]

The Podcast by KevinMD

December 23, 2025Dec 23, 2025

Pediatric endocrinologist Shara Bialo discusses her article, "Why type 1 diabetes screening should be part of back-to-school." She highlights that back-to-school visits are a critical window to screen for type 1 diabetes (T1D), a disease where sixty-two percent of new…

Listen on Apple Podcasts · Spotify

Listen and followApple Podcasts Spotify YouTubeMore apps · Browse all episodes

Pediatric endocrinologist Shara Bialo discusses her article, “Why type 1 diabetes screening should be part of back-to-school.” She highlights that back-to-school visits are a critical window to screen for type 1 diabetes (T1D), a disease where sixty-two percent of new cases currently result in life-threatening hospitalizations. Shara shares her personal …

Conditions and diseases

My journey to a type 1 diabetes diagnosis

Beth Thacker

November 6, 2025Nov 6, 2025

I was diagnosed with type 1 diabetes mellitus in February 2024. Now it all made sense. It all started in October 2020 when I passed out cold. I was rushed to the emergency room and 3 days later woke up…

I was diagnosed with type 1 diabetes mellitus in February 2024. Now it all made sense.

It all started in October 2020 when I passed out cold. I was rushed to the emergency room and 3 days later woke up to find I had a thyroid issue and lost 2 pints of blood. Four days later, after a blood transfusion, I was sent home. At that point, I thought I was …

Physician voices

Paraphimosis and diabetes: the hidden link

Shirisha Kamidi, MD

November 3, 2025Nov 3, 2025

Paraphimosis is a urological emergency characterized by the inability to reduce a retracted foreskin over the glans penis, leading to vascular congestion, edema, and potential tissue necrosis. While paraphimosis can result from local trauma, poor hygiene, or iatrogenic causes, it is increasingly recognized as a clinical manifestation associated with underlying systemic disease, particularly diabetes mellitus.

Diabetes mellitus, especially when undiagnosed or poorly controlled, exerts profound effects on local tissue immunity, wound …

Conditions and diseases

CRISPR therapy offers hope for diabetes

Cliff Dominy, PhD

October 28, 2025Oct 28, 2025

In a major advance in medicine, a man with type 1 diabetes is making his own insulin again, this time using genetically engineered donor islet cells. Researchers provided the new cells with an invisibility cloak to allow them to escape immune detection. After three months of follow-up, his body had not only accepted the new tissue but was quietly producing insulin. This single-patient proof-of-concept study gives hope to the millions …

Read more…

CRISPR therapy offers hope for diabetes

Conditions and diseases

Are SGLT2 inhibitors safe for type 1 diabetes?

Zehra Haider, MD

October 22, 2025Oct 22, 2025

SGLT2 inhibitors have transformed care for people with type 2 diabetes. They not only lower blood sugar but also reduce cardiovascular events and slow the progression of kidney disease. Given these successes, many have asked whether the same benefits extend…

The answer is not straightforward. In T1D, SGLT2 inhibitors remain off-label, and the biggest concern is the increased risk of diabetic ketoacidosis (DKA). Still, …

Conditions and diseases

Life after GLP-1s: How to sustain weight loss

Ricky Bloomfield, MD

October 12, 2025Oct 12, 2025

It should come as no surprise that GLP-1 receptor agonists have revolutionized the management of obesity and metabolic syndrome. These drugs have shown extraordinary promise in regulating appetite, promoting weight loss, and improving blood sugar control. Nearly one in eight adults (twelve percent) have taken a GLP-1 agonist, and forty-three percent of adults diagnosed with diabetes have used these therapies, numbers likely to have increased further in the last year …

Conditions and diseases

Why type 1 diabetes screening should be part of back-to-school

Shara Bialo, MD

September 24, 2025Sep 24, 2025

Back-to-school season is one of the busiest times of the year for health care providers (HCPs). Doctors' offices are full of young patients and families preparing for the year ahead, checking off physical exams, immunization forms, and age-based screenings. These…

Back-to-school season is one of the busiest times of the year for health care providers (HCPs). Doctors’ offices are full of young patients and families preparing for the year ahead, checking off physical exams, immunization forms, and age-based screenings. These visits are more than just routine; they are critical opportunities to talk about risk factors and catch early signs of health issues. Yet too often, one disease slips through the …

The Podcast by KevinMD

How Ukrainian doctors sustained diabetes care during the war [PODCAST]

The Podcast by KevinMD

September 6, 2025Sep 6, 2025

Physician Daryna Bahriy discusses her article "How Ukrainian doctors kept diabetes care alive during the war," sharing how medical teams in western Ukraine adapted to protect vulnerable patients amid the chaos of conflict. Daryna explains how disrupted supply chains threatened…

Listen on Apple Podcasts · Spotify

Listen and followApple Podcasts Spotify YouTubeMore apps · Browse all episodes

Physician Daryna Bahriy discusses her article “How Ukrainian doctors kept diabetes care alive during the war,” sharing how medical teams in western Ukraine adapted to protect vulnerable patients amid the chaos of conflict. Daryna explains how disrupted supply chains threatened insulin access, how doctors rapidly coordinated resource redistribution, and how …

Conditions and diseases

Why GLP‑1 drugs should be covered beyond weight loss

Rodney Lenfant

September 4, 2025Sep 4, 2025

When I turned 50, I weighed 265 pounds. Over the next 12 years, through walking, yoga, and strength training, I lost 60 pounds and kept it off. But despite the discipline, I remained plagued by inflammation, pain, and sleep apnea.…

Then last year, my doctor suggested tirzepatide (Zepbound), not just for weight loss but to treat my sleep apnea as well. That alternative diagnosis unlocked insurance coverage and led to a …

Diabetes care

Articles, page 2

Real physician voices, twice a week

The Podcast

Latest episodes

Most popular

The Podcast

Latest episodes

Most popular